An efficient tool to link X-ray experiments and ab initio theory
The electronic structure of complex molecules can be assessed by the method of resonant inelastic X-ray scattering (RIXS) at BESSY II. © Martin Künsting /HZB
The electronic structure of complex molecules and their chemical reactivity can be assessed by the method of resonant inelastic X-ray scattering (RIXS) at BESSY II. However, the evaluation of RIXS data has so far required very long computing times. A team at BESSY II has now developed a new simulation method that greatly accelerates this evaluation. The results can even be calculated during the experiment. Guest users could use the procedure like a black box.
Molecules consisting of many atoms are complex structures. The outer electrons are distributed among the different orbitals, and their shape and occupation determine the chemical behaviour and reactivity of the molecule. The configuration of these orbitals can be analysed experimentally. Synchrotron sources such as BESSY II provide a method for this purpose: Resonant inelastic X-ray scattering (RIXS). However, to obtain information about the orbitals from experimental data, quantum chemical simulations are necessary. Typical computing times for larger molecules take weeks, even on high-performance computers.
Speeding up the evaluation
"Up to now, these calculations have mostly been carried out subsequent to the measurements", explains theoretical chemist Dr. Vinicius Vaz da Cruz, postdoc in Prof. Dr Alexander Föhlisch's team. Together with the RIXS expert Dr. Sebastian Eckert, also a postdoc in Föhlisch's team, they have developed a sophisticated new procedure that speeds up the evaluation many times over.
"With our method, it takes a few minutes and we don't need a super-computer for this, it works on desktop machines," says Eckert. The HZB scientists have tested the method on the molecule 2-thiopyridone, a model system for proton transfer, which are essential processes in living cells and organisms. Despite the short computing time, the results are precise enough to be very useful.
"This is a huge step forward," emphasises Föhlisch. "We can run through many options in advance and get to know the molecule, so to speak. In addition, this method also makes it possible to simulate far more complex molecules and to interpret the experimentally obtained data in a meaningful way". Experimental physicist Eckert adds: "We can now also run the simulations during the measurement and see immediately where it might be particularly exciting to take a closer look”.
The procedure is an extension of the well established and highly efficient time-dependent density functional theory, which is much faster than the traditional concepts to simulate the RIXS process. "The simplicity of the method allows for a large degree of automatization," says Vaz da Cruz: "It can be used like a black box."
- Catalysis research at HZB gets new facilityAs part of the CatLab project, HZB has acquired a unique facility for measuring the catalytic performance of thin-film catalysts. Built by ILS in Adlershof, it has now been delivered. The facility consists of a total of eight chemical reactors in which catalytic systems can be tested. At over €2.5 million, this is the largest single investment in the CatLab project.
- Protein crystallography at BESSY II: faster, better and more and more automaticMany diseases are linked to malfunctions of proteins in the organism. The three-dimensional architecture of these molecules is often highly complex, but it can provide valuable insights into biological processes and the development of drugs. X-ray diffraction at the MX beamlines of BESSY II can be used to decipher the 3D structure of proteins. To date, more than 5000 structures have been solved at the three MX beamlines. Here, we present a review and an outlook with Manfred Weiss, head of the research group for macromolecular crystallography.
- 5000th protein structure at BESSY II: Starting point for a COVID drugMany proteins have a complex architecture that enables biological functions. Molecules can bind to specific sites on a protein and alter its function. A team at HZB has now investigated the Nsp1 protein, which plays a role in infection with the SARS-CoV-2 virus. They analysed protein crystals, previously mixed with molecules from a fragment library, and discovered a total of 21 candidates as starting points for drug development. At the same time, they also decoded the 5000th structure at BESSY II.